Loading company…
SPT Labtech Limited, formerly TTP Labtech, provides instruments and solutions for drug discovery and genomics research.
Founded in 2001 and based in Melbourne, England, SPT Labtech Limited, formerly known as TTP Labtech Limited, offers data-driven solutions for life sciences, including drug discovery, molecular biology, genomics and structural biology. In June 2022, EQT agreed to acquire the company from Battery Ventures for GBP 650 million. David Newble has been CEO since at least January 2024. Notable partners include GlaxoSmithKline, Dart NeuroScience and Abcam.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in